3,586 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by GraniteShares Advisors LLC

GraniteShares Advisors LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,586 shares of the medical equipment provider’s stock, valued at approximately $1,210,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. OFI Invest Asset Management acquired a new stake in Intuitive Surgical during the 3rd quarter worth $25,000. Baystate Wealth Management LLC raised its stake in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares in the last quarter. Headinvest LLC acquired a new stake in Intuitive Surgical during the 3rd quarter worth $28,000. Stone House Investment Management LLC grew its position in Intuitive Surgical by 100.0% during the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC purchased a new position in Intuitive Surgical during the 3rd quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have issued reports on ISRG. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research report on Friday, January 19th. Citigroup raised their price objective on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Finally, Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $375.70.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded up $1.19 on Tuesday, hitting $378.55. The stock had a trading volume of 1,602,973 shares, compared to its average volume of 1,636,060. The firm has a market capitalization of $134.18 billion, a price-to-earnings ratio of 75.03, a P/E/G ratio of 5.97 and a beta of 1.36. The stock’s 50 day moving average is $388.13 and its 200-day moving average is $341.56. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.48 by $0.12. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The company had revenue of $1.93 billion during the quarter, compared to analyst estimates of $1.89 billion. During the same period last year, the business earned $0.91 EPS. The firm’s revenue for the quarter was up 16.6% compared to the same quarter last year. Equities analysts expect that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In related news, VP Fredrik Widman sold 5,041 shares of Intuitive Surgical stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $397.07, for a total value of $2,001,629.87. Following the sale, the vice president now directly owns 110 shares in the company, valued at approximately $43,677.70. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 20,296 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the transaction, the executive vice president now owns 5,507 shares of the company’s stock, valued at approximately $2,168,656.60. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Fredrik Widman sold 5,041 shares of the firm’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the transaction, the vice president now directly owns 110 shares in the company, valued at approximately $43,677.70. The disclosure for this sale can be found here. In the last three months, insiders have sold 248,418 shares of company stock worth $95,927,097. 0.80% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.